Inflammatory biomarkers IL-1β, IL-6, IL-8, IL-10, and TNFα were all significantly elevated in the NAFLD/NASH patients, with respect to control participants and patients with simple steatosis. The gene discussed is CXCL8; the disease is metabolic dysfunction-associated steatotic liver disease.